has been cited by the following article(s):
[1]
|
Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study
Targeted Oncology,
2017
DOI:10.1007/s11523-017-0531-4
|
|
|